FDA’s first new motion sickness drug in decades may matter more for GLP-1 side effects
The FDA’s Dec. 30 approval of Vanda Pharmaceuticals’ Nereus (tradipitant) adds a rare new option to a category that has leaned for decades on older anticholinergics and antihistamines, including the scopolamine patch and over-the-counter products such as meclizine and dimenhydrinate....
The business case for ambulatory growth, despite lower pay
Health system C-suites across the U.S. are targeting ambulatory care expansion for 2026 as pressure mounts to lower cost of care and deliver on value-based promises. Even the nation’s largest health systems are strengthening their ambulatory footprints. Chicago-based CommonSpirit Health,...
20,000 nurses at 12 New York City hospitals give strike notice
The New York State Nurses Association delivered 10-day strike notices Jan. 2 to 12 hospitals in New York City. Here are seven things to know: 1. If agreements are not reached, as many as 20,000 nurses could strike Jan. 12. This would mark the largest nurse strike in city history, according to a...<![CDATA[JP Morgan 2026 Preview: What Path Will Pfizer Take?]]>
Continue reading →![<![CDATA[Hoth Therapeutics Files Two Provisional Patent Applications to Expand Product Portfolio ]]>](https://theindustryexpert.com/wp-content/uploads/2026/01/86c1d1a69215b5d64ec55097a79929f3c2e1f93f-1280x720-1.png)
![<![CDATA[FDA Approves Nereus for the Prevention of Motion Induced Vomiting ]]>](https://theindustryexpert.com/wp-content/uploads/2026/01/ab965ea0a889f2c2a2a31157d46dc13fdc90c31e-1280x720-1.png)
McDonald’s rolls out global Happy Meal experience with Crayola
The item features space-themed activity kits and toys, as well as a digital element Continue reading →
Noodles & Company receives delisting determination letter
The fast-casual restaurant chain appealed the delisting and has proposed a reverse stock split Continue reading →